© 2004 by BMJ Publishing Group Ltd & European League Against Rheumatism
REPORT
New targets IIIpathways
A toll for T cell costimulation
Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK
Correspondence to:
Correspondence to:
F Y Liew
Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow G11 6NT, UK; fyl1h@clinmed.gla.ac.uk
Abbreviations: APC, antigen presenting cell; BLP, bacterial lipoprotein; IFN, interferon; IL, interleukin; LPS, lipopolysaccharide; PAMP, pathogen associated molecular pattern; Th, T helper; TCR, T cell receptor; TLR, toll-like receptor
Keywords: toll-like receptor; T cell receptor; antigen presenting cell; bacterial lipoprotein; TLR2; TLR signalling
| The first 150 words of the full text of this article appear below. |
Toll was originally found in Drosophila as a pattern recognition receptor associated with defence against fungal and bacterial infections.1,2 Subsequently, toll was found in mammals and named toll-like receptor (TLR). At least 10 distinct TLRs have now been identified in humans.39 TLRs are activated by pathogen associated molecular patterns (PAMPs) with target selectivity. PAMPs are integral structural components of pathogens that are thus thought to be essential for survival of infectious organisms and considered to be conserved among a range of pathogens including viruses, bacteria, and fungi.
TLRs act as primary sensors of microbial products and activate signalling pathways that lead to the induction of immune and inflammatory genes.10 They belong to a broader family of proteins, which includes receptors for the proinflammatory cytokines interleukin (IL)-1, IL-18 and the orphan receptor T1/ST2.11 All members of this superfamily signal inflammation in a very similar manner. This is due
This article has been cited by other articles:
-
Thibault, S., Tardif, M. R., Barat, C., Tremblay, M. J.
(2007). TLR2 Signaling Renders Quiescent Naive and Memory CD4+ T Cells More Susceptible to Productive Infection with X4 and R5 HIV-Type 1. J. Immunol.
179: 4357-4366
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
